Epimmune Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Epimmune Inc..The latest application filed is for "inducing cellular immune responses to plasmodium falciparum using peptide and nucleic acid compositions".

Company Profile

0.15.13

Epimmune Inc. - San Diego CA US
Epimmune Inc. - Genencore International, Inc.
Epimmune Inc. - 5820 Nancy Ridge Road San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
PAN-DR binding polypeptides and uses thereof Grant 9,789,181 - Dal Degan , et al. October 17, 2	2017-10-17
Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions Grant 9,511,134 - Alexander , et al. December 6, 2	2016-12-06
Inducing Cellular Immune Responses to Plasmodium Falciparum Using Peptide and Nucleic Acid Compositions App 20160193316 - Sette; Alessandro ; et al.	2016-07-07
HLA binding motifs and peptides and their uses Grant 9,340,577 - Grey , et al. May 17, 2	2016-05-17
PAN-DR Binding Polypeptides and Uses Thereof App 20160114035 - Degan; Florence Dal ; et al.	2016-04-28
Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions Grant 9,266,930 - Sette , et al. February 23, 2	2016-02-23
Pan-DR binding polypeptides and uses thereof Grant 9,249,187 - Degan , et al. February 2, 2	2016-02-02
PAN-DR Binding Polypeptides and Uses Thereof App 20110293646 - Degan; Florence Dal ; et al.	2011-12-01
Plasmodium falciparum antigens and methods of use Grant 8,017,745 - Sette , et al. September 13, 2	2011-09-13
Optimized multi-epitope constructs and uses thereof Grant 7,888,472 - Sette , et al. February 15, 2	2011-02-15
Optimized Multi-Epitope Constructs and Uses Thereof App 20100068218 - SETTE; Alessandro ; et al.	2010-03-18
Optimized multi-epitope constructs and uses thereof App 20070048330 - Sette; Alessandro ; et al.	2007-03-01
Plasmodium falciparum antigens and methods of use App 20060165719 - Sette; Alessandro ; et al.	2006-07-27
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions Grant 7,026,443 - Sette , et al. April 11, 2	2006-04-11
Inducing cellular immune responses to human immunodeficiency virus-1 using peptide and nucleic acid compositions App 20050271676 - Sette, Alessandro ; et al.	2005-12-08
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions App 20050063983 - Sette, Alessandro ; et al.	2005-03-24
Induction of immune response against desired determinants App 20050049197 - Sette, Alessandro ; et al.	2005-03-03
CTL inducing peptides from c-erb2 (HER-2/neu) App 20040157780 - Grey, Howard M. ; et al.	2004-08-12
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions Grant 6,689,363 - Sette , et al. February 10, 2	2004-02-10
HLA class I A2 tumor associated antigen peptides and vaccine compositions Grant 6,602,510 - Fikes , et al. August 5, 2	2003-08-05
Heteroclitic analogs and related methods App 20030143672 - Tangri, Shabnam ; et al.	2003-07-31
Expression vectors for stimulating an immune response and methods of using the same Grant 6,534,482 - Fikes , et al. March 18, 2	2003-03-18
Induction of immune response against desired determinants Grant 6,413,935 - Sette , et al. July 2, 2	2002-07-02
Identification of broadly reactive DR restricted epitopes Grant 6,413,517 - Sette , et al. July 2, 2	2002-07-02
Methods for making HLA binding peptides and their uses Grant 6,037,135 - Kubo , et al. March 14, 2	2000-03-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.